GlobeNewswire Inc.··Not SpecifiedTaysha Gene Therapies to Report Q1 2026 Results, Discuss Clinical Pipeline Progress
Taysha Gene Therapies will report Q1 2026 financial results and discuss TSHA-102 Rett syndrome program progress on May 6, 2026.
TSHAclinical-stagegene therapy